medigraphic.com
ISSN 2007-2783 (Print)
Órgano Oficial del Instituto Científico Pfizer

2010, Number 3

<< Back

Residente 2010; 5 (3)

Repercusiones médicas, sociales y económicas del insomnio

Haro VR, Labra HA, Sánchez NF

Language: Spanish
References: 59
Page: 130-138
PDF size: 217.89 Kb.


ABSTRACT

Insomnia is present at any age, but it becomes more evident as years go by. The estimated prevalence of insomnia differs greatly among the different publications, due to the definition used and the types of insomnia studied. Statistically significant associations between this sleep disorder and a several somatic and mental diseases have been found, and there is controversy as for the causal relationship between insomnia and depression. Insomnia indirect costs are a lot much higher than the direct medical costs, but as it was mentioned in relation to prevalence, the estimations have methodological problems that make them controversial. The impact of insomnia on work is important, and, as for therapeutic choices, they may be combined to obtain better results. The current concepts related to insomnia as a health problem are analyzed in this chapter, from Sleep Medicine’s perspective. The aim is to synthesize the estimations of insomnia prevalence, its different forms of expression, and explore its impact on people’s health, labor productivity and the consumption of health resources, as well to review the therapeutic choices that have proved to be efficient for the treatment of insomnia.


REFERENCES

  1. Suarez-Rodriguez A, Robles-Garcia B. Hábitos de sueño en la revisión del niño sano. Bol Pediatr 2005; 45: 17-22.

  2. Levy D, Gray-Donald K, Leech J et al. Sleep patterns and problems in adolescents. J Adolesc Heath Care 1986; 7: 386-389.

  3. Kirmil-Gray K, Eaglestone JR, Gibson E, et al. Sleep disturbance in adolescents: sleep quality, sleep habits, beliefs about sleep, and daytime functioning. J Youth Adolesc 1984; 13: 375-384.

  4. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA 1989; 262: 1479-1484.

  5. Ohayon MM, Caulet M, Lemoine P. Comorbidity of mental and insomnia disorders in the general population. Compr Psychiatry 1998; 39: 185-197.

  6. Ohayon MM, Roth T. What are the contributing factors for insomnia in the general population? J Psychosom Res 2001; 51: 745-755.

  7. Ancoli-Israel S, Roth T. Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I. Sleep. 1999; 22(suppl 2): S347-S353.

  8. Ishigooka J, Suzuki M, Isawa S, Muraoka H, Murasaki M, Okawa M. Epidemiological study of sleep habits and insomnia of new outpatients visiting general hospitals in Japan. Psychiatry Clin Neurosci 1999; 53: 515-522.

  9. Simon GE, VonKorff M. Prevalence, burden, and treatment of insomnia in primary care. Am J Psychiatry 1997;154: 1417-1423.

  10. Yeo BK, Perera IS, Kok LP et al. Insomnia in the community. Singapore Med J 1996; 37: 282-284.

  11. Janson C, Norbäck D, Omenaas E, Gislason T, Nyström E, Jõgi R, Lindberg E, Gunnbjörnsdottir M, Norman E, Wentzel-Larsen T, Svanes C, Jensen EJ, Torén K. Insomnia is more common among subjects living in damp buildings. Occup Environ Med 2005; 62: 113-118.

  12. Trujillo de los Santos Z. Insomnio en el paciente geriátrico. Arch Neurocien (Mex) 1997; 2: 122-127.

  13. Pando-Moreno M, Aranda-Beltran C, Aguilar-Aldrete ME, Mendoza-Roaf PL, Salazar-Estrada J. Prevalencia de los trastornos del sueño en el adulto mayor. Cad. Saúde Pública, Rio de Janeiro 2001; 17(1): 63-69.

  14. Husby R, Lingjaerde O. Prevalence of reported sleeplessness in northern Norway in relation to sex, age and season. Acta Psychiatr Scand 1990; 81: 542-547.

  15. Morgan K, Clarke D. Risk factors for late-life insomnia in a representative general practice sample. Br J Gen Pract 1997; 47: 166-169.

  16. Li RHY, Wing YK, Ho SC et al. Gender differences in insomnia –a study in the Hong Kong Chinese population. J Psychosom Res 2002; 53: 601-609.

  17. Reyner LA, Horne JA, Reyner A. Gender and age-related differences in sleep determined by home recorded sleep logs and actimetry from 400 adults. Sleep 1995; 18: 127-134.

  18. Rey de Castro J, Vizcarra D. Frecuencia de síntomas del síndrome apnea hipopnea del sueño e insomnio en médicos de una clínica privada peruana. Rev Med Hered 2003; 14: 53-58.

  19. Francisco-Baez G, Flores-Correa N, González-Sandoval T, Horrisberger H. Calidad del sueño en estudiantes de medicina. Revista de Postgrado de la VI Cátedra de Medicina 2005; 141: 14-17.

  20. Durand G, Rey de Castro J. Hábitos y trastornos del sueño en rotadores de turnos de trabajo en una fábrica de bebidas. An Fac Med Univ Nac S Marcos 2004; 65: 97-102.

  21. Geroldi C, Frisoni GB, Rozzini R, De Leo D, Trabucchi M. Principal lifetime occupation and sleep quality in the elderly. Gerontology 1996; 42: 163-9.

  22. Pacheco-Quesada GM, Rey-De-Castro MJ. Insomnio en pacientes adultos ambulatorios de medicina interna del Hospital Nacional Arzobispo Loayza. Rev Med Hered 2003; 14: 63-68.

  23. Arias-Congrains J. Omisión en el registro de insomnio en pacientes internados en un hospital general. Rev Med Hered 2003; 14: 59-62.

  24. Rey-De-Castro MJ, Álvarez-Mayorga J, Gaffo A. Síntomas relacionados a trastornos del sueño en supuestos sanos que asisten a un centro de Atención Primaria de Salud. Rev Med Hered 2005;16: 31-38.

  25. Alvarado R. Frecuencia del insomnio en México. Arch Neurocien (Mex) 1997; 2: 114-121.

  26. Benca RM. Consequences of insomnia and its therapies. J Clin Psychiatry 2001; 62(suppl 10): 33-38.

  27. Neubauer DN. Chronic insomnia: current issues. Clin Cornerstone 2004; 6(Suppl 1C): S17-S22.

  28. Benca RM, Obermeyer WH, Thisted RA, Guillin JC. Sleep and psychiatric disorders: A meta-analysis. Arch Gen Psychiatry 1992; 49: 651-668.

  29. Breslau N, Roth T, Rosenthal L, Andreski P. Sleep disturbance and psychiatric disorders: A longitudinal epidemiological study of young adults. Biol Psychiatry 1996; 39: 411-418.

  30. Chang PP, Ford DE, Mead LA et al. Insomnia in young men and subsequent depression. The Johns Hopkins Precursors Study. Am J Epidemiol 1997; 146: 105-114.

  31. Morawetz D. Insomnia and depression: Which comes first? Sleep Research Online 2003; 5(2): 77-81.

  32. Gillin JC. Are sleep disturbances risk factors for anxiety, depressive and addictive disorders? Acta Psychiatr Scand Suppl 1998; 98: 39-43.

  33. Riemann D, Voderholzer U. Primary insomnia: a risk factor to develop depression? J Affect Disord 2003; 76: 255-259.

  34. Chilcott LA, Shapiro CM. The socioeconomic impact of insomnia – an overview. Pharmacoeconomics 1996; 10: 1-14.

  35. Dement WC, Mitler MM. It´s time to wake up to the importance of sleep disorders. JAMA 1993; 269: 1548-1549.

  36. National Institutes of Health. State-of-the-Science Conference Statement on Manifestations and Management of Chronic Insomnia in Adults; June 13-15, 2005. Sleep 2005; 28: 1049-1057.

  37. Walsh J, Engelhardt C. The direct economic costs of insomnia in the United States for 1995. Sleep 1999; 22(Suppl 2): S386-S393.

  38. Leger D, Levy E, Paillard M. The direct costs of insomnia in France. Sleep 1999; 22(Suppl 2): S394-S401.

  39. Stoller MK. Economic effects of insomnia. Clin Ther 1994; 16(5): 873-897.

  40. Martin SA, Aiken JE, Chervin RD. Toward cost-effectiveness analysis in the diagnosis and treatment of insomnia. Sleep Medicine Reviews 2004; 8: 63-72.

  41. González-Silva M. Enfermedades del sueño y su impacto laboral. Ciencia & Trab 2004; 6(12): 48-52.

  42. Metlaine A, Leger D, Choudat D. Socioeconomic impact of insomnia in working populations. Industr Health 2005; 43:11-19.

  43. Leigh JP. Employee and job attributes as predictors of absenteeism in a national sample of workers: the importance of health and dangerous conditions. Soc Sci Med 1991; 33: 127-37.

  44. Åkerstedt T, Fredlund P, Gillberg M, Jansson B. A prospective study of fatal occupational accidents—relationship to sleeping difficulties and occupational factors. J Sleep Res 2002; 11: 69-71.

  45. Léger D, Guilleminault C, Bader G, Levy E, Paillard M. Medical and socioprofessional impact of insomnia. Sleep 2002; 25: 625-9.

  46. Fullerton P. The economic impact of insomnia in managed care: A clearer picture emerges. Am J Manag Care 2006; 12: S246-S252.

  47. Sivertsen B, Overland S, Neckelmann D, Glozier N, Krokstad S, Pallesen S, Nordhus IH, Bjorvatn B, Mykletun A. The Long-term Effect of Insomnia on Work Disability. The HUNT-2 Historical Cohort Study. Am J Epidemiol 2006; 163: 1018-1024.

  48. Zammit GK, Weiner J, Damato N, Sillup GP, McMillan CA. Quality of life in people with insomnia. Sleep 1999; 22: S379-S385.

  49. Leger D, Scheuermaier K, Philip P, Paillard M, Guilleminault C. SF-36: Evaluation of quality of life in severe and mild insomniacs compared with good sleepers. Psychosom Med 2001; 63: 49-55.

  50. Katz DA, McHorney CA. The relationship between insomnia and health-related quality of life in patients with chronic illness. J Fam Pract 2002; 51: 229-235.

  51. Roth T, Ancoli-Israel S. Daytime consequences and correlates of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. II. Sleep 1999; 22(Suppl 2): S354-8.

  52. Jiménez-Genchi A, Díaz-Ceballos MA. El insomnio en la práctica médica. Rev Fac Med UNAM 2000; 43(2): 46-48.

  53. ORGANIZACIÓN PANAMERICANA DE LA SALUD. Insomnio. Guía de diagnóstico y manejo. Disponible en: http://www.sld.cu/galerias/pdf/sitios/gericuba/guia23.pdf

  54. Drake CL, Roehrs T, Roth T. Insomnia causes, consequences, and therapeutics: an overview. Depres Anxiety 2003; 18: 163-176.

  55. Hoehns JD, Perry PJ. Zolpidem: a nonbenzodiazepine hypnotic for treatment of insomnia. Clin Pharm 1993; 12: 814-28.

  56. Smith MT, Perlis ML, Park A, Smith MS, Pennington J, Giles DE, Buysse DJ. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry 2002; 159: 5-11.

  57. Wang MY, Wang SY, Tsai PS. Cognitive behavioral therapy for primary insomnia: a systematic review. Journal Adv Nurs 2005; 50(5): 553-564.

  58. Morgan K, Dixon S, Mathers N, Thompson J, Tomeny M. Psychological treatment for insomnia in the management of long-term hypnotic drug use: a pragmatic randomized controlled trial. Brit J Gen Prac 2003; 53: 923-928.

  59. Morin CM, Colecchi C, Stone J, Sood R, Brink D. Behavioral and pharmacological therapies for late-life insomnia: A randomized controlled trial. JAMA 1999; 281: 991-999.




2020     |     www.medigraphic.com